Kolexia
Couraud Sebastien Pneumologie
Couraud Sebastien
Pneumologie
Hôpital Lyon Sud
Pierre-Bénite, France
524 Activités
4.2 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Adénocarcinome COVID-19 Métastase tumorale Cellules tumorales circulantes Carcinomes Maladies pulmonaires

Collaborateurs

Voir plus
Souquet Pierre Jean
Souquet Pierre Jean
Hôpital Lyon Sud, Pierre-Bénite, France
Greillier Laurent
Greillier Laurent
Hôpital Nord Marseille, Marseille, France
Cortot Alexis
Cortot Alexis
Hôpital Albert Calmette, Lille, France
Morere Jean François
Morere Jean François
Hôpital Paul Brousse, Villejuif, France

Industries

Voir plus
AstraZeneca
21 collaboration(s)
Dernière en 2023
BMS
11 collaboration(s)
Dernière en 2023
Amgen
5 collaboration(s)
Dernière en 2023
Novartis
5 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3): Randomized, Open-label, Multicenter, Phase 3 Trial of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)
Essai Clinique (BMS)   11 mars 2024
SyPoCo: Post-Covid Syndrome Cohort
Essai Clinique (Hospices Civils de Lyon)   26 février 2024
SMALLHAN: Assessment of Tobacco Smoking and Alcohol Drinking and Treatment Outcomes Among Patients With Lung or Head and Neck Cancer
Essai Clinique (Hospices Civils de Lyon)   16 février 2024
TAXIO: A Phase II Study Assessing the Efficacy of Etoposide Free Chemotherapy Plus Durvalumab (MEDI4736) in First Line Extensive Disease Small Cell Lung Cancer (SCLC)
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   18 décembre 2023
MONITOR: Impact of Telemonitoring for the Management of Side Effects in Patients With Melanoma, Lung or Renal Cancer, Treated With Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy
Essai Clinique (Hospices Civils de Lyon)   11 décembre 2023
70P LIST (Lung Initiative on Sequence Therapy): A real-world study of nivolumab for advanced NSCLC in France - First effectiveness, safety, and IO-rechallenge results
Abstract Book of the ESMO Immuno-Oncology Congress 2023 6-8 December 2023   01 décembre 2023
ULYSSE: Prospective Longitudinal Cohort Associated to Blood Collection, Pathological Samples Collection, and Radiological and Pathological Imaging Collection
Essai Clinique (Hospices Civils de Lyon)   20 novembre 2023
MADMAS: Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Patients With Lung and Head and Neck Cancers, Treated With an Immunotherapy-based Therapy
Essai Clinique (Hospices Civils de Lyon)   15 novembre 2023
Comparison and Validation of Rapid Molecular Testing Methods for Theranostic Epidermal Growth Factor Receptor Alterations in Lung Cancer: Idylla versus Digital Droplet PCR.
International journal of molecular sciences   27 octobre 2023
Les traitements périopératoires des cancers bronchiques non à petites cellules (CBNPC) : standards actuels et perspectives – de la chimiothérapie aux inhibiteurs des checkpoints immunitaires: Perioperative treatments for non-small cell lung cancer (NSCLC): Current standards and perspectives – from chemotherapy to immune checkpoint inhibitors
Revue des maladies respiratoires actualites   01 octobre 2023